[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Prof. Dr. Paul Brinkkoetter\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":19,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100358661",false,"NCT03949972","The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)","FOrMe","Inclusion Criteria (cohort A):\n\n* written informed consent\n* 17 or less years of age\n* idiopathic nephrotic syndrome\n\nInclusion Criteria (cohort B):\n\n* written informed consent\n* older or equal to 18 years of age\n* biopsy-proven primary or secondary FSGS or MCD or biopsy-proven recurrence of disease in kidney transplant.\n\nExclusion Criteria (both cohorts):\n\n* Prior kidney transplant without biopsy-proven recurrence\n* A clinical diagnosis of other glomerular disease resulting in secondary MCD or FSGS as judged by the treating physicians.\n* Refusal to provide written informed consent\n* (Anticipated) incompliance with visit schedule","ALL",{"count":17,"type":18},500,"ESTIMATED","15 Years","OBSERVATIONAL","In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.",[23,24,25],"Glomerulosclerosis, Focal Segmental","Minimal Change Disease","Idiopathic Nephrotic Syndrome",[27,28,29,30,31,32],"Focal and Segmental Glomerulosclerosis","Focal & Segmental Glomerulosclerosis","FSGS","Minimal change disease","MCD","Nephrotic Syndrome","RECRUITING","2025-09-11",{"date":36,"type":37},"2025-09-17","ACTUAL",{"date":39,"type":37},"2018-04-01",{"date":41,"type":18},"2033-03-31",{"name":43,"class":44},"Prof. Dr. Paul Brinkkoetter","OTHER",12,""]